MLS-101
Mineralys therapeutics
['erda', 'cardio']
we re presenting data from the first-in-human study of lorundrostat at #acc23 #wccardio today at 12:45pm et. for more, read yesterday s press release for results from the target-htn ph2 trial: 
We're a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for hypertension.